UNLOCKING AI-RADIOLOGY & PATHOLOGY.
DELIVERING CARES, FASTER.
ABOUT
Revolutionizing Radiology & Pathology. Accelerating Drug Discovery. Powered by our AI.
Empowering healthcare professionals with more time for patient care.
Neu (Neuro / New) + Perspective = Neuspective
MVV
Mission — Why We Exist
- Through technology, we create new time to devote to life itself — and restore what only humans can do.
- テクノロジーで、いのちに向き合う新たな時間の創出と、人しかできない本質を、取り戻す。
Vision — What We Aim to Achieve
- Unlocking the value of radiology and pathology through technology.
- 放射線科、病理診断科から、その価値をテクノロジーで解き放つ。
Values — How We Act
- Speed & Iteration: Move fast, tackle challenges head-on. Test early, validate early.
- 迅速に動き、課題に取り組む。早く世の中に試して、早く検証する。
- Partnership: Build mutual respect and trust — internally and externally — to become the people and company others choose to work with.
- 社内外ともに相互の尊重・信頼を置き、選ばれる人・会社にする。
- Entrepreneurship: Read the currents of change and keep challenging the status quo with bold, creative ambition.
- 潮流を掴み、創造的野心のもと、常に挑戦する。
- Tenacity: Never give up easily.
- 粘り強く、簡単に諦めない。
- On-the-Ground Strength: Mobilize mind, hands, and feet to grasp the reality on the ground — not just probabilities or narratives.
- 頭・手・足を総動員し、確率や言説ではなく、現場のリアルを捉える。
NEWS
Recognized through various acceleration programs, awards, and speaking engagements.
PRODUCTS
Transforming Diagnostic Reporting
We are revolutionizing reporting workflows in Radiology and Pathology through AI. Our core expertise is developing applications that fuse advanced voice recognition with sophisticated text expression capabilities.
Our unique approach creates a synergy between Functions (such as voice-to-text, auto-correction, and scoring) and Values (Accuracy, Efficiency, and Speed). This modular framework allows us to build customized solutions that perfectly match on-site clinical requirements.
Reach out to learn more.
AI-Powered Reporting for Radiology & Pathology
VALUE PROPOSITION:
- 7 human errors check items
- ≈0 manual revision
- 1.5x reading time
- 10x speed for guideline verification
AI Symptom Checker
- QOL Evaluation App for Heart Failure
- Medication Management & Monitoring App
- Medical Interview
Research & Development
- Engaged in various joint R&D initiatives
MORE >>
TEAM
– Leadership
武田 康宏
Yasuhiro Takeda
Co-founder / CEO
Bio: MS from the Department of Technology Management for Innovation (TMI), The University of Tokyo. Co-founded the company in 2024 with Professor Muragaki, his former attending surgeon who treated his brain tumor. Muragaki is a leading authority in the development of novel treatments for malignant brain tumors, surgical navigation systems, and medical robotics.
He served as a Project Academic Specialist at The University of Tokyo’s Matsuo-Iwasawa Lab (Currently: the Network for Global Entrepreneurship (NGE)). In these roles, he led lectures, incubation programs, and international relations, specifically establishing Deep Tech entrepreneurship courses and building startup communities. He also participated in multiple healthcare-related projects.
Earlier in his career at Mitsubishi Research Institute (MRI), he engaged in healthcare business strategy, Finance x AI projects, and research on quantum computing, future studies, and well-being.
Certifications:
- MIT Professional Education in Technology Roadmapping
- UTokyo STIG (Science, Technology, and Innovation Governance) program
- Matsuo Lab’s comprehensive AI courses:
- GCI (Data Science)
- Deep Learning
- Deep Generative Models
- Deep Reinforcement Learning
- World Models
– Engineer
- PhD in Particle and Astrophysical Physics from Nagoya University
- Interns
– Researcher
- MD, Radiologist from Kanazawa University
- MD & PhD, Cardiologist from The University of Tokyo, University of Cambridge
- Radiological Technologist from Hirosaki University
Partner / Joined Program
CONTACT
Join us. Empowering healthcare professionals with more time for patient care.